Amylyx Pharmaceuticals, Inc.
AMLX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34 | -$41 | -$36 | -$38 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $7 | $7 |
| Change in WC | -$2 | $10 | -$11 | -$27 |
| Other Non-Cash | $6 | $6 | $0 | -$2 |
| Operating Cash Flow | -$30 | -$25 | -$40 | -$59 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$59 | -$39 | $0 | $0 |
| Inv. Sales/Matur. | $64 | $62 | $0 | $65 |
| Other Inv. Act. | $0 | $0 | -$44 | $0 |
| Investing Cash Flow | $5 | $23 | -$44 | $65 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $191 | $0 | $66 | $0 |
| Stock Issued | $3 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$1 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$0 | $1 | $0 |
| Financing Cash Flow | $192 | -$0 | $66 | $0 |
| Forex Effect | $1 | $1 | $0 | -$1 |
| Net Chg. in Cash | $167 | -$2 | -$18 | $6 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $58 | $60 | $79 | $73 |
| End Cash | $225 | $58 | $61 | $79 |
| Free Cash Flow | -$30 | -$25 | -$40 | -$59 |